Safety and efficacy of fruquintinib-based therapy in patients with advanced or metastatic sarcoma.

Published in: Cancer medicine (2024)

Fruquintinib-based therapy displayed an optimal tumor control and an acceptable safety profile in patients with advanced or metastatic sarcoma.

Keyphrases